Dialectic Therapeutics
Phase 1/2Dialectic Therapeutics’ mission is to create innovative new technologies to treat cancer. Our goal is to relieve the suffering of patients with cancer, to give them hope and prolong their productive lives through targeted therapies with limited toxicities and complications.
Founded
2018
Focus
Small Molecules
About
Dialectic Therapeutics’ mission is to create innovative new technologies to treat cancer. Our goal is to relieve the suffering of patients with cancer, to give them hope and prolong their productive lives through targeted therapies with limited toxicities and complications.
Funding History
2Total raised: $25M
Series A$20MUndisclosedMar 15, 2023
Seed$5MUndisclosedJun 15, 2021
Company Info
TypePrivate
Founded2018
LocationDallas, United States
StagePhase 1/2
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile